Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis.
Berry JD, Paganoni S, Harms MB, Shneider N, Andrews J, Miller TM, Babu S, Sherman AV, Harris BT, Provenzano FA, Phatnani HP, Shefner J, Garret MA, Ladha SS, Tsou AY, Mohan P, Igne C; ALL ALS Consortium; Bowser R. Berry JD, et al. Among authors: miller tm. Muscle Nerve. 2024 Dec;70(6):1140-1150. doi: 10.1002/mus.28244. Epub 2024 Sep 18. Muscle Nerve. 2024. PMID: 39295118 Review.
Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives.
Lee I, Garret MA, Wuu J, Harrington EA, Berry JD, Miller TM, Harms M, Benatar M, Shneider N. Lee I, et al. Among authors: miller tm. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Nov;25(7-8):672-679. doi: 10.1080/21678421.2024.2396831. Epub 2024 Aug 27. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 39192497
Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement.
Thota R, Hurley PA, Miller TM, Bruinooge SS, Lipset C, Harvey RD, Black LJ, Dinsdale A, Merrill JK, Pollastro T, Prindiville SA, Rizvi MA, Sherwood S, Nowakowski GS. Thota R, et al. Among authors: miller tm. J Clin Oncol. 2024 Nov 20;42(33):3986-3995. doi: 10.1200/JCO.24.00961. Epub 2024 Jul 30. J Clin Oncol. 2024. PMID: 39079075
Rare variant analyses validate known ALS genes in a multi-ethnic population and identifies ANTXR2 as a candidate in PLS.
Pottinger TD, Motelow JE, Povysil G, Moreno CAM, Ren Z, Phatnani H; New York Genome Center ALS Sequencing Consortium; Aitman TJ, Santoyo-Lopez J; Scottish Genomes Partnership; Mitsumoto H; ALS COSMOS Study Group; PLS COSMOS Study Group; GTAC Investigators; Goldstein DB, Harms MB. Pottinger TD, et al. BMC Genomics. 2024 Jun 29;25(1):651. doi: 10.1186/s12864-024-10538-1. BMC Genomics. 2024. PMID: 38951798 Free PMC article.
295 results